1-9 of 9
Brian C Sauer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Shifting Treatment Patterns and Clinical Outcomes in Veterans Diagnosed with Waldenstrom Macroglobulinemia from 2006 to 2018

Free
Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Vikas Patil, MS, Kelli M Rasmussen, BSc,MS, Christina Yong, MA, Catherine Li, PhD, Zachary R Burningham, PhD, Brian C Sauer, PhD, Ahmad S Halwani, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12.
https://doi.org/10.1182/blood-2020-141427
Published: 2020
Journal Articles

Discontinuation Patterns in Patients Receiving Novel Oral Agents for Chronic Lymphocytic Leukemia in the Veterans Health Administration

Free
Hsu-Chih Chien, PhD MSc, Vikas Patil, MS, Kelli M Rasmussen, MS, Christina Yong, MA, Juliana M L Biondo, MD, Mary Halloran, PharmD, BCPS, Sheila Shapouri, PharmD, MS, Mei Wu, PharmD, Zachary R Burningham, PhD, Brian C Sauer, PhD, Ahmad S Halwani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4309.
https://doi.org/10.1182/blood-2019-128645
Published: 2019
Journal Articles

Real-World Practice Patterns in a Nationwide Cohort of Veterans with Waldenström's Macroglobulinemia

Free
Kelli M Rasmussen, MS, Vikas Patil, MS, Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Catherine Li, PhD, Zachary R Burningham, PhD, Brian C Sauer, PhD, Ahmad S Halwani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5270.
https://doi.org/10.1182/blood-2019-127738
Published: 2019
Journal Articles

Survival Patterns in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: Treatment Trajectories and Responses after the First Relapse

Free
Ahmad S Halwani, MD, Hsu-Chih Chien, PhD MSc, Deborah Kay Morreall, BS, Vikas Patil, MS, Kelli M Rasmussen, MS, Catherine Li, PhD, Zachary R Burningham, PhD, Anthony S Masaquel, PhD MPH, Mary Halloran, PharmD, BCPS, Elisha Delong-Sieg, PharmD, Mathias Schulz, MD MBA, Jia Li, PhD, Brian C Sauer, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1622.
https://doi.org/10.1182/blood-2019-127719
Published: 2019
Journal Articles

Factors Associated with Overall Survival in Follicular Lymphoma Patients Who Are Eligible for Maintenance Therapy

Free
Ahmad S Halwani, MD, Kelli M Rasmussen, MS, Vikas Patil, MS, Zachary Burningham, PhD, Catherine Li, PhD, Christina Young, MA, Anthony Masaquel, PhD MPH, Kevin Henderson, PharmD, MBA, Elisha Delong-Sieg, PharmD, Brian C Sauer, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4159.
https://doi.org/10.1182/blood-2018-99-115722
Published: 2018
Journal Articles

Treatment Practices and Outcomes in Older Adults with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the Veterans Health Administration

Free
Ahmad S Halwani, MD, Kelli M Rasmussen, MS, Vikas Patil, MS, Catherine Li, PhD, Christina Young, MA, Zachary Burningham, PhD, Mathias Schulz, MD MBA, Jia Li, PhD, Anthony Masaquel, PhD MPH, Mary Halloran, PharmD, Elisha Delong-Sieg, PharmD, Brian C Sauer, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4205.
https://doi.org/10.1182/blood-2018-99-116695
Published: 2018
Journal Articles

Maintenance Rituximab after First Line Treatment in Veterans with Follicular Lymphoma Is Associated with Prolonged Overall Survival

Free
Ahmad S. Halwani, MD, Kelli Rasmussen, MS, Vikas Patil, MS, Zach Burningham, PhD, Clarke Low, MD, Carolina M Reyes, PhD, Anthony Masaquel, MPH, PhD, Kevin Henderson, PharmD, MBA, Elisha Delong-Sieg, PharmD, Brian C Sauer, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1489.
https://doi.org/10.1182/blood.V130.Suppl_1.1489.1489
Published: 2017
Journal Articles

Incidence of Atrial Fibrillation and Bleeding in CLL Patients Treated with Ibrutinib: Evidence from the Veterans Health Administration

Free
Ahmad S. Halwani, MD, Kelli Rasmussen, MS, Vikas Patil, MS, Zachary Burningham, PhD, Brian C Sauer, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5336.
https://doi.org/10.1182/blood.V130.Suppl_1.5336.5336
Published: 2017
Journal Articles

Evaluating Mortality with Erythropoietin Stimulating Agents (ESAs) in the Oncology Setting: The Importance of Selecting Trials That Include Survival or Loco-Regional Tumor Control as a Primary Endpoint

Free
Athena T Samaras, BA, Sara E Barnato, MD, Benjamin Kim, MD, Stephen Y Lai, MD, PhD, A. Oliver Sartor, MD, June McKoy, MD, JD, MPH, Brian C Sauer, PhD, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2008) 112 (11): 4681.
https://doi.org/10.1182/blood.V112.11.4681.4681
Published: 2008